Married with three children, Mary Ellen lives in the Bronx, N.Y., and likes hiking in the Adirondacks. But until she learned how to manage her Type 2 diabetes, she was tired and hungry all the time.
Mary Ellen tried insulin injections and then switched to the Lantus SoloStar insulin pen, which has a push-button system with a small, thin needle. “I found the pen easier to use and much more discreet,” she confides in a video clip at WhyInsulin.com.
More related to this story
- Big Pharma's calling the shots
- The man from Pfizer: Should Big Pharma help steer health research?
- Drug R&D costs are less than estimated – so why the high prices?
The health site – run by the pharmaceutical company Sanofi-Aventis – portrays Mary Ellen as a typical middle-aged woman who put her family’s health before her own.
But the website does not clarify that Mary Ellen and other patients featured in its “insulin success stories” are paid spokespersons for the drug company, according to a formal complaint submitted in November to the U.S. Federal Trade Commission.
Prepared by four separate watchdog groups, the 144-page report cites dozens of examples of pharmaceutical marketing on the Web that “threatens consumer privacy and engages in unfair and deceptive practices.”
Monday, July 25, 2011
Big Pharma wants to ‘friend’ you - The Globe and Mail
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment